Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population

The purpose of this study is to evaluate the safety,tolerability,pharmacokinetics and pharmacodynamics of VB19055 in the healthy Chinese population.

Participants needed: 86
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd.Updated: Nov 28, 2025Locations: 2
Eligibility criteria

Voluntarily participate in clinical trials, understand the nature of the study a... [+4]

Known allergy to aldosterone synthase inhibitors or any components/excipients of... [+20]

Status: Recruiting

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

This research is designed to determine if experimental treatment with PARP1 inhibitor, VB15010 is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.

Participants needed: 188
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Zhejiang Yangli Pharmaceutical Technology Co., Ltd.Updated: Feb 11, 2025Locations: 1
Eligibility criteria

Age ≥ 18 at the time of screening; [+4]

Major surgery within 4 weeks of the first dose of study treatment. [+2]